AdvisorShare Pure US Cannabis ETF MSOS

In a recent issue of "Cannabis Confidential," Todd Harrison provides a succinct analysis of the current market dynamics within the cannabis industry, particularly highlighting the performance of AdvisorShares Pure US Cannabis ETF (NYSE: MSOS). Harrison, known for his expertise in...

Equity research firm Zuanic & Associates convened a panel in mid-June featuring industry experts to dissect the ongoing cannabis rescheduling efforts in the US. They provided a comprehensive outlook on the rescheduling process, expected to conclude with the publication of the Final Rule in the...

Recent news that the Department of Health and Human Services (HHS) is recommending the reclassification of marijuana as a Schedule III drug under the Controlled Substances Act has ignited significant market reactions. On the day following the report, MSOS ETF (ARCA: MSOS) surged...